Big News in HIV Prevention: Lenacapavir Coming to Africa with U.S. Government Support
The U.S. government, through the President’s Emergency Plan for AIDS Relief (PEPFAR), has announced a groundbreaking commitment to expand access to lenacapavir for pre-exposure prophylaxis (PrEP). This long-acting twice-yearly injectable for HIV prevention will be...
ACRN at SACRA 2025 – Day 1 Highlights
Yesterday marked ACRN’s first time attending the SACRA South Africa SACRA Conference, an important moment as we joined Africa’s clinical research community to connect, learn, and expand partnerships. Our team – Romina Mariano (Chief of Staff), Wilfred Gurupira...
Community-led Innovation in Action: Mutala at the Community Engagement Network Forum 2025
At the current Community Engagement Network Forum 2025 in Cape Town, our Community Engagement Officer, Takura mangwiro presented how Mutala, ACRN’s primary clinical trial site, is applying insights from the Zimbabwe Engage Study to strengthen participant...
From Discovery to Impact: The IDRL Story
During the recent Zimbabwe Annual Scientific Conference (ZASCO), hosted with support from the Zimbabwe National Quality Assurance Program (ZINQAP), Dr Alltalents Tutsirayi Murahwa, PhD, our Laboratory Director and Head of Research, shared the journey of ACRN’s...